Targeting BCMA Achieves Deep and Durable Responses in Multiple Myeloma.
Sign Up to like & getrecommendations! Published in 2019 at "Cancer discovery"
DOI: 10.1158/2159-8290.cd-rw2018-203
Abstract: Targeting BCMA with the antibody-drug conjugate GSK2857916 is well tolerated in a phase I trial. read more here.
Keywords: targeting bcma; bcma achieves; responses multiple; durable responses ... See more keywords